BridgeMD
Prevention study for Depression, Postpartum
Official title From Prevention to Treatment: How Biological Rhythms Can Maintain Perinatal Mental Health
ClinicalTrials.gov ID: NCT06246214
What this study is testing
- What it's testing
- Depression and anxiety are significant public health issues during pregnancy and the postnatal period, particularly affecting those in developing countries. Disruptions in biological rhythms, sleep problems, and low exposure to daylight are associated with a higher risk of these mental health issues.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- 4-6 weeks postpartum;
- Postnatal depression confirmed through Edinburgh Postnatal Depression Scale (EPDS) \> 10;
- Mini-International Neuropsychiatric Interview (M.I.N.I.) positive for current depressive episode.
You likely can't join if
- Active suicidal ideation;
- Psychotic symptoms;
- Unstable general medical conditions that interfere with the acquisition of actigraphy;
- Newborn with severe health conditions (hospitalization, care in the neonatal ICU).
The study team makes the final eligibility decision.
Where it's taking place
- Porto Alegre, Rio Grande do Sul, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Porto Alegre, Rio Grande do Sul, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.